The global critical care drugs market is witnessing substantial expansion, fueled by the increasing prevalence of life-threatening conditions and the growing demand for advanced medical interventions. With a projected compound annual growth rate (CAGR) of 5.1% from 2024 to 2034, the market is set to surge from USD 1,052 million in 2024 to an estimated …